Do analysts recommend APHA or PBH?

Premium Brands has a consensus target price of C$118.62, indicating a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher possible upside, analysts plainly believe Premium Brands is more favorable than Aphria. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Premium Brands 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92

Which has higher earnings & valuation, APHA or PBH?

Premium Brands has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aphria C$611.06M 0.00 -C$637.39M -C$2.01 N/A Premium Brands C$7.88B 0.57 C$99.56M C$0.90 95.68

Do analysts prefer BHC or PBH?

Premium Brands has a consensus price target of C$118.62, suggesting a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher probable upside, analysts plainly believe Premium Brands is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Premium Brands 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92

Does the media favor BHC or PBH?

In the previous week, Bausch Health Companies and Bausch Health Companies both had 1 articles in the media. Premium Brands' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.80 indicating that Premium Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch Health Companies 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Premium Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PBH or SLS?

In the previous week, Premium Brands and Premium Brands both had 1 articles in the media. Premium Brands' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Premium Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Solaris Resources 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate AUP or PBH?

Premium Brands has a consensus target price of C$118.62, indicating a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher probable upside, analysts clearly believe Premium Brands is more favorable than Aurinia Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Premium Brands 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92

Do analysts rate PBH or CARA?

Premium Brands presently has a consensus price target of C$118.62, suggesting a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher possible upside, equities analysts plainly believe Premium Brands is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Premium Brands 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, PBH or CARA?

Premium Brands has higher revenue and earnings than Cara Operations. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Premium Brands C$7.88B 0.57 C$99.56M C$0.90 95.68 Cara Operations N/A N/A N/A N/A N/A

Premium Brands (PBH) Competitors

C$86.11 +0.56 (+0.65%)

As of 06/9/2026 04:00 PM Eastern

Compare

PBH vs. APHA, BHC, SLS, AUP, and CARA

Should you buy Premium Brands stock or one of its competitors? MarketBeat compares Premium Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Premium Brands include Aphria (APHA), Bausch Health Companies (BHC), Solaris Resources (SLS), Aurinia Pharmaceuticals (AUP), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Premium Brands compare to Aphria?

Aphria (TSE:APHA) and Premium Brands (TSE:PBH) are both mid-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Premium Brands has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A
Premium Brands	C$7.88B	0.57	C$99.56M	C$0.90	95.68

Premium Brands has a consensus target price of C$118.62, indicating a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher possible upside, analysts plainly believe Premium Brands is more favorable than Aphria.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92

In the previous week, Premium Brands had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Premium Brands and 0 mentions for Aphria. Aphria's average media sentiment score of 0.00 equaled Premium Brands'average media sentiment score.

Company	Overall Sentiment
Aphria	Neutral
Premium Brands	Neutral

31.8% of Premium Brands shares are held by institutional investors. 2.0% of Premium Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Premium Brands has a net margin of 0.52% compared to Aphria's net margin of 0.00%. Premium Brands' return on equity of 2.21% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aphria	N/A	N/A	N/A
Premium Brands	0.52%	2.21%	3.61%

Summary

Premium Brands beats Aphria on 13 of the 13 factors compared between the two stocks.

How does Premium Brands compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Premium Brands (TSE:PBH) are both mid-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Premium Brands has a net margin of 0.52% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Premium Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Premium Brands	0.52%	2.21%	3.61%

Premium Brands has a consensus price target of C$118.62, suggesting a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher probable upside, analysts plainly believe Premium Brands is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92

Premium Brands has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.26	-C$125.65M	-C$3.24	N/A
Premium Brands	C$7.88B	0.57	C$99.56M	C$0.90	95.68

In the previous week, Bausch Health Companies and Bausch Health Companies both had 1 articles in the media. Premium Brands' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.80 indicating that Premium Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch Health Companies	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Premium Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

10.1% of Bausch Health Companies shares are held by institutional investors. Comparatively, 31.8% of Premium Brands shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Comparatively, 2.0% of Premium Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Bausch Health Companies has a beta of 0.942978, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Premium Brands has a beta of 0.88205, suggesting that its share price is 12% less volatile than the broader market.

Summary

Premium Brands beats Bausch Health Companies on 10 of the 15 factors compared between the two stocks.

How does Premium Brands compare to Solaris Resources?

Premium Brands (TSE:PBH) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Premium Brands has a net margin of 0.52% compared to Solaris Resources' net margin of 0.00%. Solaris Resources' return on equity of 60.97% beat Premium Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Premium Brands	0.52%	2.21%	3.61%
Solaris Resources	N/A	60.97%	-51.67%

Premium Brands has a beta of 0.88205, indicating that its share price is 12% less volatile than the broader market. Comparatively, Solaris Resources has a beta of 1.721408, indicating that its share price is 72% more volatile than the broader market.

31.8% of Premium Brands shares are held by institutional investors. Comparatively, 16.4% of Solaris Resources shares are held by institutional investors. 2.0% of Premium Brands shares are held by company insiders. Comparatively, 40.6% of Solaris Resources shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Premium Brands and Premium Brands both had 1 articles in the media. Premium Brands' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Premium Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solaris Resources	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Premium Brands has higher revenue and earnings than Solaris Resources. Solaris Resources is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Premium Brands	C$7.88B	0.57	C$99.56M	C$0.90	95.68
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

Premium Brands currently has a consensus target price of C$118.62, suggesting a potential upside of 37.75%. Solaris Resources has a consensus target price of C$19.50, suggesting a potential upside of 65.82%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts plainly believe Solaris Resources is more favorable than Premium Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Premium Brands beats Solaris Resources on 8 of the 13 factors compared between the two stocks.

How does Premium Brands compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Premium Brands (TSE:PBH) are both mid-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Premium Brands has a consensus target price of C$118.62, indicating a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher probable upside, analysts clearly believe Premium Brands is more favorable than Aurinia Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92

In the previous week, Premium Brands had 1 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 1 mentions for Premium Brands and 0 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.00 equaled Premium Brands'average media sentiment score.

Company	Overall Sentiment
Aurinia Pharmaceuticals	Neutral
Premium Brands	Neutral

Premium Brands has a net margin of 0.52% compared to Aurinia Pharmaceuticals' net margin of 0.00%. Premium Brands' return on equity of 2.21% beat Aurinia Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Premium Brands	0.52%	2.21%	3.61%

31.8% of Premium Brands shares are owned by institutional investors. 2.0% of Premium Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Premium Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Aurinia Pharmaceuticals is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A
Premium Brands	C$7.88B	0.57	C$99.56M	C$0.90	95.68

Summary

Premium Brands beats Aurinia Pharmaceuticals on 13 of the 13 factors compared between the two stocks.

How does Premium Brands compare to Cara Operations?

Premium Brands (TSE:PBH) and Cara Operations (TSE:CARA) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Premium Brands pays an annual dividend of C$3.40 per share and has a dividend yield of 3.9%. Cara Operations pays an annual dividend of C$0.41 per share. Premium Brands pays out 377.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Premium Brands presently has a consensus price target of C$118.62, suggesting a potential upside of 37.75%. Given Premium Brands' stronger consensus rating and higher possible upside, equities analysts plainly believe Premium Brands is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Premium Brands has a net margin of 0.52% compared to Cara Operations' net margin of 0.00%. Premium Brands' return on equity of 2.21% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Premium Brands	0.52%	2.21%	3.61%
Cara Operations	N/A	N/A	N/A

31.8% of Premium Brands shares are owned by institutional investors. 2.0% of Premium Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Premium Brands has higher revenue and earnings than Cara Operations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Premium Brands	C$7.88B	0.57	C$99.56M	C$0.90	95.68
Cara Operations	N/A	N/A	N/A	N/A	N/A

In the previous week, Premium Brands had 1 more articles in the media than Cara Operations. MarketBeat recorded 1 mentions for Premium Brands and 0 mentions for Cara Operations. Premium Brands' average media sentiment score of 0.00 equaled Cara Operations'average media sentiment score.

Company	Overall Sentiment
Premium Brands	Neutral
Cara Operations	Neutral

Summary

Premium Brands beats Cara Operations on 11 of the 12 factors compared between the two stocks.

Get Premium Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PBH vs. The Competition

Export

Metric	Premium Brands	Packaged Foods Industry	Defensive Sector	TSE Exchange
Market Cap	C$4.48B	C$4.61B	C$8.32B	C$12.74B
Dividend Yield	3.97%	2.57%	3.22%	6.20%
P/E Ratio	95.68	2,848.71	891.65	36.68
Price / Sales	0.57	3,430.46	992,149.57	10.18
Price / Cash	97.88	119.32	140.90	82.29
Price / Book	1.92	22.48	9.63	4.38
Net Income	C$99.56M	C$2.71B	C$1.03B	C$299.09M
7 Day Performance	-5.83%	-0.19%	0.12%	-2.58%
1 Month Performance	-4.16%	1.29%	-0.11%	-2.14%
1 Year Performance	6.32%	722.29%	255.53%	41.49%

Premium Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PBH Premium Brands	3.2714 of 5 stars	C$86.11 +0.7%	C$118.62 +37.7%	+7.3%	C$4.48B	C$7.88B	95.68	540
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
BHC Bausch Health Companies	0.5575 of 5 stars	C$6.97 -5.3%	N/A	+8.4%	C$2.75B	C$10.53B	N/A	19,900	High Trading Volume
SLS Solaris Resources	1.5211 of 5 stars	C$15.25 +3.4%	C$19.50 +27.9%	+91.5%	C$2.46B	N/A	N/A	10
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:PBH) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Premium Brands (PBH) Competitors

PBH vs. APHA, BHC, SLS, AUP, and CARA

How does Premium Brands compare to Aphria?

Summary

How does Premium Brands compare to Bausch Health Companies?

Summary

How does Premium Brands compare to Solaris Resources?

Summary

How does Premium Brands compare to Aurinia Pharmaceuticals?

Summary

How does Premium Brands compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBH vs. The Competition

Premium Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Premium Brands (PBH) Competitors

PBH vs. APHA, BHC, SLS, AUP, and CARA

How does Premium Brands compare to Aphria?

Which has higher earnings & valuation, APHA or PBH?

Do analysts recommend APHA or PBH?

Does the media prefer APHA or PBH?

Do insiders and institutionals hold more shares of APHA or PBH?

Is APHA or PBH more profitable?

Summary

How does Premium Brands compare to Bausch Health Companies?

Is BHC or PBH more profitable?

Do analysts prefer BHC or PBH?

Which has higher valuation and earnings, BHC or PBH?

Does the media favor BHC or PBH?

Do institutionals & insiders hold more shares of BHC or PBH?

Which has more volatility & risk, BHC or PBH?

Summary

How does Premium Brands compare to Solaris Resources?

Is PBH or SLS more profitable?

Which has more volatility and risk, PBH or SLS?

Do institutionals and insiders have more ownership in PBH or SLS?

Does the media prefer PBH or SLS?

Which has better valuation and earnings, PBH or SLS?

Do analysts rate PBH or SLS?

Summary

How does Premium Brands compare to Aurinia Pharmaceuticals?

Do analysts rate AUP or PBH?

Does the media prefer AUP or PBH?

Is AUP or PBH more profitable?

Do institutionals & insiders have more ownership in AUP or PBH?

Which has better earnings & valuation, AUP or PBH?

Summary

How does Premium Brands compare to Cara Operations?

Is PBH or CARA a better dividend stock?

Do analysts rate PBH or CARA?

Is PBH or CARA more profitable?

Do institutionals & insiders have more ownership in PBH or CARA?

Which has better earnings and valuation, PBH or CARA?

Does the media refer more to PBH or CARA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBH vs. The Competition

Premium Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools